6 of Wall Street's Favorite High-Yield Blue Chip Dividend Stocks to Buy in June24/7 Wall Street • 06/17/24
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a DecadeThe Motley Fool • 06/15/24
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid TumorsBusiness Wire • 06/13/24
Dividend Harvesting Portfolio Week 171: $17,100 Allocated, $1,524.12 In Projected DividendsSeeking Alpha • 06/13/24
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers SquibbAccesswire • 06/12/24
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 06/11/24
Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare ConferenceSeeking Alpha • 06/11/24
Dividend Harvesting Portfolio Week 170: $17,000 Allocated, $1,515.47 In Projected DividendsSeeking Alpha • 06/06/24
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersPRNewsWire • 06/05/24
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)Zacks Investment Research • 06/05/24
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW TrialBusiness Wire • 06/04/24
Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceBusiness Wire • 06/04/24